BioCardia Completes Enrollment Of CardiAMP Cell Therapy For Treatment Of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort
BioCardia Completes Enrollment Of CardiAMP Cell Therapy For Treatment Of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.